Ibio Inc stock is traded at $0.7919, with a volume of 144,081. It is down -3.92% in the last 24 hours and down -12.32% over the past month. iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Previous Close:
$0.8242
Open:
$0.83
24h Volume:
144,081
Relative Volume:
0.39
Market Cap:
$55.79M
Revenue:
$300.00K
Net Income/Loss:
-$27.61M
P/E Ratio:
-
EPS:
-$0.5777
Net Cash Flow:
-$22.17M
1W Performance:
+8.46%
1M Performance:
-12.32%
6M Performance:
-50.81%
1Y Performance:
-36.65%
1-Day Range:
$0.77$0.8321
1-Week Range:
$0.7126$0.8345
52-Week Range:
$0.6859$3.82
Ibio Inc Stock (IBIO) Company Profile
Name
Ibio IncSector
HealthcareIndustry
BiotechnologyPhone
302 355-0650Address
600 MADISON AVENUE, SUITE 1601, NEW YORK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS